This guess is taking a lot of things into consideration - but the primary 3 are:
(1) # of shares outstanding when all is said and done and MNKD is able to cashflow themselves thru sales,
(2) management incompetence issues,
offset by,
(3) the dire need for this drug.
$12.50
Thanks all for your input here - I follow the board diligently. I'm one for brevity and trying to cut thru as much bs as possible.